Manage the people you've connected with and see who's online now.
Loading your friends
No friends found
Connect with people to see them here.
Your direct and group chats, end-to-end encrypted.
Loading your conversations
No conversations yet
Message a friend or start a group to begin.
No friends to add
Connect with people first.
Mentions, replies, and account activity in one place.
Your browser language:
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other drugs, while those already struggling with addiction experienced fewer overdoses, hospitalizations, emergency visits, and
Turning complex stories into clear, actionable insights.
Complete the captcha to unlock Maximus
Share this article:
ScienceDaily
Brought to you by InfomundiLike this publisher? Add them to your personal feed and combine publishers, tags, and categories to build a custom news page just for you.
Related coverage
Tags
lower risks massive study veterans suggests weight loss weight-loss drugsGlobal Coverage
This story is being covered by 0 countries
Trending